Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyMyelomaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
A MyMyelomaTeam Member asked a question πŸ’­
Pretoria, ZA
July 24
 · 
Be the first to react
MyMyelomaTeam

Myeloma is classified based on the type of abnormal antibody (M protein) that the cancerous plasma cells produce. Here's a breakdown of the main types:

By antibody type
- IgG myeloma – The most common type, affecting about 2 in 3 people with myeloma
- IgA myeloma – The second most common, affecting about 1 in 5 people
- Show Full Answer

Myeloma is classified based on the type of abnormal antibody (M protein) that the cancerous plasma cells produce. Here's a breakdown of the main types:

By antibody type:
- IgG myeloma – The most common type, affecting about 2 in 3 people with myeloma
- IgA myeloma – The second most common, affecting about 1 in 5 people
- IgD, IgM, and IgE myeloma – These are rarer forms

By protein production:
- Light chain myeloma (Bence-Jones myeloma) – Plasma cells produce only light chain proteins (either kappa or lambda), not full antibodies. This affects about 15% of people with myeloma
- Nonsecretory myeloma – A rare type where cancerous plasma cells don't produce any M protein at all, making it harder to track Myeloma can also be described by how it behaves over time:

- Relapsed myeloma – Myeloma that returns after a treatment that previously worked
- Refractory myeloma – Myeloma that continues to progress despite treatment, which can be harder to manage

Knowing your specific type helps your care team track the disease and choose the most effective treatment plan for you.

July 24

Related Questions

View All
A MyMyelomaTeam Member asked a question πŸ’­
Bristol, RI

A MyMyelomaTeam Member asked a question πŸ’­
Winnipeg, MB

Continue with Facebook
Continue with Google
By joining, you accept our Terms of Use, and acknowledge our collection, sharing, and use of your data in accordance with our Health Data and Privacy policies.
Already a member? Log In